By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel is bearish on Onto Innovation due to concerns about ASP compression from multi-vendor qualification, cyclical capex risks, and unquantified margins.
Risk: ASP compression from multi-vendor qualification and cyclical capex risks
Opportunity: Initial wins in advanced packaging with Dragonfly tools
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Onto Innovation Inc. (NYSE:ONTO) is one of the best hot stocks to buy for June. On June 4, Stifel reiterated Onto Innovation Inc. (NYSE:ONTO) as a Buy with a $350 price target. The research firm remains bullish on the company, impressed by the accelerated adoption of its inspection technology by customers.
The company’s long-term prospects for Dragonfly inspection tools also remain intact, with qualification by two key high-bandwidth memory and foundry logic customers. Management had expected the qualification to take three to six months. Stifel expects the faster-than-expected qualification to act as a catalyst, strengthening the company’s sentiment in the second half of the year.
In addition, the research firm expects Onto Innovation to benefit from the strengthening demand for G3 advanced packaging inspection in high-bandwidth memory and foundry logic systems. Consequently, advanced packaging inspection revenue is expected to grow by more than 50%, and overall revenue to grow by more than 30%.
Onto Innovation Inc. (NYSE:ONTO) is a leading U.S. semiconductor company that designs and builds the advanced equipment and software required to manufacture microchips. Their technology enables chipmakers to inspect microscopic defects, measure nanoscale chip structures, and automate production processes, thereby improving overall yield and reliability.
While we acknowledge the potential of ONTO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 8 Best Defensive Stocks to Buy Amid Geopolitical Tensions and 10 Best Forever Stocks to Buy According to Analysts.
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"Faster qualifications alone do not de-risk ONTO’s revenue trajectory given the cyclical and concentrated nature of advanced packaging demand."
The article frames faster Dragonfly qualifications and >30% revenue growth as near-term catalysts for ONTO, yet omits any valuation context or competitive dynamics. Semiconductor inspection demand is highly cyclical and concentrated among a handful of memory and logic customers; any delay in HBM ramps or capex cuts by TSMC or Samsung would quickly reverse the narrative. Stifel's $350 target implies significant multiple expansion that has not been stress-tested against current booking linearity or margin sustainability in advanced packaging. The piece also downplays that ONTO's growth is largely derivative of broader AI-driven capex rather than proprietary moat expansion.
Even if qualifications accelerate, KLA-Tencor’s larger installed base and process-control integration could capture most incremental spend, leaving ONTO with share gains too small to justify the implied re-rating.
"ONTO's upside hinges on a rapid, durable rebound in semiconductor capex and Dragonfly qualification success, which would unlock the anticipated >30% revenue growth and >50% in advanced packaging inspection."
Onto Innovation stands to benefit from a renewed semiconductor capex cycle, with Dragonfly qualification and stronger G3 advanced packaging inspection driving near-term revenue upside. The bullish note from Stifel and the expectation of >30% total revenue growth imply continued outsized demand for high-end inspection tools as memory and logic foundries expand packaging capabilities. However, the thesis rests on cyclical demand and execution: a slower-than-expected qualification, slower adoption by major customers, or a backlash in capex could erode multiples. Competitive pressure from KLA, AMAT, and smaller peers, plus potential margin compression in a hardware cycle, could cap upside if hysteresis persists.
Against this, a longer-than-expected qualification delay or a downturn in semiconductor capex due to softer AI spending could derail the upside; in a cyclical hardware cycle, even solid growth may fail to sustain multiple expansion if margins compress.
"Onto Innovation's valuation is justified by its role as a critical gatekeeper for HBM yield, provided foundry capex remains robust throughout 2025."
Onto Innovation is riding a clear tailwind from the transition to 3D packaging, specifically the shift toward High Bandwidth Memory (HBM) where defect density is a critical yield killer. With a forward P/E currently hovering near 35x-40x, the market is already pricing in that 30% revenue growth. The real story here isn't just 'inspection'; it's the necessity of Dragonfly tools for CoWoS (Chip-on-Wafer-on-Substrate) processes. If they maintain their lead in nano-scale metrology, they become an essential tollbooth for AI hardware production. However, investors should be wary of the high beta; any cyclical cooling in foundry capex will hit ONTO significantly harder than diversified equipment giants like Applied Materials.
The thesis relies on rapid HBM qualification, but if yield improvements at major foundries stabilize faster than expected, the urgency for Onto's specific inspection tools could plateau, leading to a valuation multiple compression.
"ONTO's upside hinges entirely on whether advanced packaging inspection capex sustains at 50%+ growth rates through 2024—a cyclical bet disguised as a secular one."
Stifel's $350 target on ONTO assumes two things: (1) Dragonfly qualifications accelerate revenue 50%+ in advanced packaging, and (2) this momentum sustains through H2. The article cites faster-than-expected qualification as a catalyst, but doesn't quantify installed base, ASP trajectory, or competitive positioning. ONTO trades on cyclical capex from foundries and memory makers—both currently constrained by overcapacity. A $350 target implies ~40% upside from typical June levels, but that assumes no revenue guidance miss and sustained 30%+ growth. The article also hedges by promoting other AI stocks, which signals the author's own conviction is mixed.
If foundry/memory capex cycles soften in H2 2024 due to inventory normalization, or if competitors (KLA, ASML) gain share in advanced packaging inspection, ONTO's 50% growth thesis collapses and the stock reprices lower despite qualification wins.
"Multiple-vendor qualification on CoWoS nodes can dilute ONTO's pricing power faster than the panel assumes, accelerating multiple compression on any H2 capex pause."
Gemini's 'essential tollbooth' claim for Dragonfly in CoWoS understates how quickly multiple suppliers can qualify on the same nodes, eroding ASPs even if ONTO wins initial sockets. Stifel's $350 target already prices 30%+ growth, yet TSMC and Samsung have both flagged H2 capex digestion; any booking linearity miss would trigger faster de-rating than the diversified equipment names. The high-beta exposure is real but unquantified here.
"Dragonfly's tollbooth status may be overstated as multiple suppliers can qualify for the same CoWoS nodes, compressing ASPs and capping ONTO's margin and revenue upside."
Responding to Gemini: The 'tollbooth' thesis hinges on Dragonfly staying uniquely superior; in practice, nodes can be qualified by several vendors, which will force ASP competition and cap margin upside. If multiple suppliers chase the same CoWoS nodes, ONTO's share of wallet could stall below expectations even with initial wins. This timing/margin risk deserves as much emphasis as the growth narrative, especially in a cyclic capex environment.
"The 'tollbooth' thesis fails to account for margin compression from rising support costs and potential customer shifts toward 'good-enough' inspection during cyclical downturns."
Gemini, the 'tollbooth' argument ignores the Opex burden of supporting these advanced nodes. As Dragonfly scales, ONTO faces significant R&D and field support costs that typically compress net margins during high-growth phases. If competition forces ASP concessions, the 'tollbooth' becomes a leaky pipe. We are ignoring the potential for a 'yield-cliff' where customers prioritize throughput over the hyper-precise inspection ONTO provides, favoring cheaper, 'good-enough' solutions from legacy incumbents like KLA during any cyclical downturn.
"The bull case collapses if ASP erosion outpaces volume growth, but nobody has modeled the margin math explicitly."
ChatGPT and Gemini both flag ASP compression from multi-vendor qualification, but neither quantifies ONTO's current gross margin or how much price erosion the model can absorb. Stifel's $350 assumes sustained 30%+ growth; if ASPs fall 15-20% while volumes grow 25%, net revenue CAGR drops materially. We need actual margin bridge assumptions, not just 'competition will compress ASPs.' That's the missing stress test.
The panel is bearish on Onto Innovation due to concerns about ASP compression from multi-vendor qualification, cyclical capex risks, and unquantified margins.
Initial wins in advanced packaging with Dragonfly tools
ASP compression from multi-vendor qualification and cyclical capex risks